Skip to main content
Log in

Inhibition of Thrombin Activity with DNA-Aptamers

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The effects of two DNA aptamers (oligonucleotides) 15TBA and 31TBA (15- and 31-mer thrombin-binding aptamers, respectively) on thrombin activity were studied. Both aptamers added to human plasma dose-dependently increased thrombin time (fibrin formation upon exposure to exogenous thrombin), prothrombin time (clotting activation by the extrinsic pathway), and activated partial thromboplastin time (clotting activation by the intrinsic pathway). At the same time, these aptamers did not modify amidolytic activity of thrombin evaluated by cleavage of synthetic chromogenic substrate. Aptamers also inhibited thrombin-induced human platelet aggregation. The inhibitory effects of 31TBA manifested at lower concentrations than those of 15TBA in all tests. These data indicate that the studied antithrombin DNA aptamers effectively suppress its two key reactions, fibrin formation and stimulation of platelet aggregation, without modifying active center of the thrombin molecule.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. A. V. Kul’bachinskii, Uspekhi Biol. Khim., 246, 193-224 (2006).

    Google Scholar 

  2. V. A. Spiridonova, E. V. Rog, T. N. Dugina, et al., Bioorgan. Khim., 29, No. 5, 495-498 (2003).

    CAS  Google Scholar 

  3. L. C. Bock, L. C. Griffin, J. A. Latham, et al., Nature, 355, 564-566 (1992).

    Article  CAS  PubMed  Google Scholar 

  4. M. Di Nisio, S. Middleldorp, and H. R. Buller, N. Engl. J. Med., 353, No. 10, 1028-1040 (2008).

    Article  Google Scholar 

  5. A. D. Ellington and J. W. Szostak, Nature, 346, 818-822 (1990).

    Article  CAS  PubMed  Google Scholar 

  6. L. C. Griffin, G. F. Tidmarsh, L. C. Bock, et al., Blood, 81, No. 12, 3271-3276 (1993).

    CAS  PubMed  Google Scholar 

  7. K. Ikebukuro, Y. Okumura, K. Sumikara, and I. Karube, Nucleic Acids Res., 33, No. 12, e108 (2005).

    Article  PubMed  Google Scholar 

  8. D. A. Lane, H. Philippou, and J. A. Huntington, Blood, 106, No. 8, 2605-2612 (2005).

    Article  CAS  PubMed  Google Scholar 

  9. A. V. Mazurov, D. V. Vinogradov, N. V. Kabaeva, et al., Thromb. Haemost., 66, No. 4, 494-499 (1991).

    CAS  PubMed  Google Scholar 

  10. S. M. Nimjee, C. P. Rusconi, R. A. Harrington, and B. A. Sullenger, Trends Cardiovasc. Med., 15, No. 1, 41-45 (2005).

    Article  CAS  PubMed  Google Scholar 

  11. C. Tuerk and L. Gold, Science, 249, 505-510 (1990).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. V. Mazurov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, No. 7, pp. 41-45, July, 2009

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dobrovolsky, A.B., Titaeva, E.V., Khaspekova, S.G. et al. Inhibition of Thrombin Activity with DNA-Aptamers. Bull Exp Biol Med 148, 33–36 (2009). https://doi.org/10.1007/s10517-009-0627-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-009-0627-7

Key Words

Navigation